INSIGHTS ON QUALITY CONTROL

• Achieving Titer Increase Up To 4-Fold While Maintaining Product Quality

  Discover customizable solutions for antibody manufacturing, as well as services for media optimization, feeding strategy optimization, and format conversion.

• Contamination Control Strategies For Innovation And Regulatory Compliance

  Creating a robust contamination control strategy is essential for pharmaceutical manufacturing. Learn to align risk management and technical controls to ensure lasting regulatory compliance.

• Improved High-Speed Performance X-Ray

  Maintain uncompromised inspection clarity at maximum operational speeds. Learn how a specialized sensor captures distortion-free imaging at 80 meters per minute.

• Environmental Monitoring In Advanced Therapeutic Medicinal Products Facilities

  Discover how to adapt your environmental monitoring framework to meet the distinct risk-management and regulatory needs of ATMP facility production.

• Monitoring Microbial Contamination Of Mammalian Cell Cultures

  2/21/2025

  Mammalian cells are widely used to produce complex processed molecules. Explore a system that effectively detects microbial contamination in mammalian cell cultures and utilizes a newly formulated lysis buffer.

• Development To Large-Scale cGMP Production

  7/25/2024

  For manufacturers working with a dry powder medium (DPM), early consultation with a supplier can increase the likelihood of success. Uncover a two-phase scale-up strategy for the production of DPM.

• Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies

  7/11/2024

  The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.

• Isokinetic Sampling In Unidirectional Flow

  3/5/2026

  Accurate cleanroom particle monitoring requires precise isokinetic sampling. Understand how to maintain sampling accuracy and meet regulatory airflow requirements for your facility.

• Ensuring Compliance For Virtual And Hybrid Pharmaceutical Companies

  10/16/2025

  Proactive, risk-based oversight must be established to manage outsourced GXP activities. This requires a robust QMS and comprehensive quality agreements to safeguard product quality and data integrity.